跳至主要内容
临床试验/NCT02797561
NCT02797561
终止
不适用

A Multicenter, Prospective Cohort to Evaluate the Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions

Seung-Jung Park18 个研究点 分布在 1 个国家目标入组 438 人2016年7月25日

概览

阶段
不适用
干预措施
5 year Follow-up
疾病 / 适应症
Percutaneous Transluminal Coronary Angioplasty
发起方
Seung-Jung Park
入组人数
438
试验地点
18
主要终点
Target vessel failure
状态
终止
最后更新
17天前

概览

简要总结

The purpose of this study is to evaluate the effect of FFR (Fractional flow reserve) guided Percutaneous Coronary Intervention in coronary tandem lesions.

注册库
clinicaltrials.gov
开始日期
2016年7月25日
结束日期
2026年4月13日
最后更新
17天前
研究类型
Observational
性别
All

研究者

发起方
Seung-Jung Park
责任方
Sponsor Investigator
主要研究者

Seung-Jung Park

professor of medicine

Asan Medical Center

入排标准

入选标准

  • Tandem lesion evaluated by FFR
  • Written consent

排除标准

  • TIMI flow \< 3
  • Grafted vessel
  • Left ventricular ejection fraction \< 30%
  • Severe calcification and/or severe tortuosity
  • Uncontrolled coronary spasm
  • Life expectancy \< 2 years
  • Planned high risk surgery
  • Pregnancy or breast-feeding

研究组 & 干预措施

Tandem lesion evaluated by FFR

干预措施: 5 year Follow-up

结局指标

主要结局

Target vessel failure

时间窗: 2 years

defined as composite event of cardiac death, non-fatal myocardial infarction, target vessel revascularization

次要结局

  • clinical predictors of events(5 years)
  • myocardial infarction(5 years)
  • Cardiac rehospitalization(5 years)
  • Cardiac death and myocardial infarction(5 years)
  • functional index(5 years)
  • all cause death(5 years)
  • cardiac death(5 years)
  • stroke(5 years)
  • angina(5 years)
  • complications with FFR(5 years)
  • target vessel revascularization(5 years)
  • target lesion revascularization(5 years)
  • death, myocardial lnfarction, revascularization(5 years)
  • stent thrombosis(5 years)
  • number of antianginal medications(5 years)

研究点 (18)

Loading locations...

相似试验